A multigene test for breast cancer recurrence risk was used in a minority of eligible patients, yet was associated with a decrease in chemotherapy use.
Lawrence H. Kushi, ScD
Advertisement
Articles by Lawrence H. Kushi, ScD
Advertisement
Latest Updated Articles
- Breast Cancer Multigene Testing Trends and Impact on Chemotherapy Use
Published: May 17th 2016 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Nerandomilast for Idiopathic Pulmonary Fibrosis
2
Pulling Back Funding for Research Could Leave HIV Treatment in Worse State: Patrick Sullivan, DVM, PhD
3
Value-Based Care Interventions and Management of CKD Progression
4
FDA Approves Cemiplimab as First, Only Adjuvant Immunotherapy for High-Risk CSCC
5
